Tag:
Axanum
Latest Headlines
Latest Headlines
European regulators greenlight AZ's Nexium combo
AstraZeneca's ( $AZN ) Nexium-plus-aspirin combo, dubbed Axanum, got the nod from European regulators. The company says it's working to get the drug onto formularies there as soon as possible. Report
FDA rejects AstraZeneca's Axanum
The FDA has declined to approve AstraZeneca's ( NYSE: AZN ) Axanum, a combination of aspirin and esomeprazole, the main ingredient in the blockbuster drug Nexium. The drug is an experimental treatment
